source
- FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1The U.S. Food and Drug Administration announced on August 5, 2026 that it has approved Orzeyful (oveporexton) tablets for adults with narcolepsy type 1. Orzeyful is the first therapy cleared to tr…
- AL Sydbank discloses share transactions by managers and related persons under MARAL Sydbank issued a company announcement (No 41/2026) on 5 August 2026, informing the market of share transactions carried out by its managers and persons closely associated with them. The disclos…